missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ IL-8 Human ProQuantum Immunoassay Kit
Measure cytokine proteins with small sample consumption and high sensitvity on a qPCR instrument
7180.00 SEK - 32130.00 SEK
Spezifikation
| Accession Number | P10145 |
|---|---|
| Assay Range | 0.0128 – 5000pg/mL |
| Assay Sensitivity | <0.01pg/mL |
| Detection Method | Taqman™ Real-time PCR |
| Product Type | ProQuantum |
| Produktcode | Marke | Quantity | Preis | Menge & Verfügbarkeit | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktcode | Marke | Quantity | Preis | Menge & Verfügbarkeit | |||||
|
15960463
|
Invitrogen™
A35575 |
96 Tests |
7180.00 SEK
96 reactions |
Estimated Shipment: 21-05-2024
Log in to see stock. |
|||||
|
17133099
|
Invitrogen™
A355755 |
5 x 96 Tests |
32130.00 SEK
Each |
Estimated Shipment: 22-05-2024
Log in to see stock. |
|||||
Beschreibung
- High-sensitivity – detect low levels of proteins with greater sensitivity than traditional methods like ELISA
- Small sample consumption – use 2-5 μL of sample (e.g., 2 μL vs 75 μL for triplicate wells with other methods)
- Fast, easy workflow – no wash steps, 2 hours from sample to answer
- Broad dynamic range – 5 logs minimizes sample dilutions to ensure falling within the range
- No proprietary instrument to purchase – runs on any real-time PCR instrument
- Includes intuitive cloud-based software – for robust data analysis and statistical group wise comparison
Spezifikation
| P10145 | |
| <0.01pg/mL | |
| ProQuantum | |
| Human | |
| qPCR Instruments | |
| GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1 | |
| FAM™ | |
| Serum, 2-5 μL; Plasma, 2-5 μL; Supernatant, 2-5 μL | |
| Human | |
| 2 hr. |
| 0.0128 – 5000pg/mL | |
| Taqman™ Real-time PCR | |
| Plasma, Serum, Supernatant | |
| Cytokine protein quantitation | |
| 3576 | |
| Assay Dilution Buffer<Br>Antibody-Conjugate A<Br>Antibody-Conjugate B<Br>Antibody-Conjugate Dilution Buffer<Br>Standard<Br>Master Mix<Br>Ligase | |
| RUO | |
| -20°C | |
| 30 min. |